<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="http://www.farmavitar.com/index2.php?option=com_xmap&amp;view=xslfile&amp;tmpl=component"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url>
<loc>http://www.farmavitar.com/</loc>
<lastmod>2010-09-08T10:53:28Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/aboutus/membership</loc>
<lastmod>2010-05-20T14:10:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/privacy-protection</loc>
<lastmod>2010-03-30T03:24:48Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/community/groups</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/community/videos</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/community/photos</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/community/search-people</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/regulatory-affairs/blog</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/blog</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/bulgaria-ra-news</loc>
<lastmod>2010-05-09T00:48:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/romania-specific-requirements</loc>
<lastmod>2010-05-06T03:02:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/administrative-fees-the-czech-r</loc>
<lastmod>2010-05-09T00:50:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/administrative-fees-romania</loc>
<lastmod>2010-05-09T01:27:38Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/update-mrp-in-hungary-as-cms</loc>
<lastmod>2010-05-09T00:53:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/new-tariffs-for-ma-in-romania</loc>
<lastmod>2010-05-09T01:27:14Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/business-advertising-activity</loc>
<lastmod>2010-05-20T21:45:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/nma-of-romania-news-flash</loc>
<lastmod>2010-05-09T01:25:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/update-on-e-ctd-submission-in-czech-republic</loc>
<lastmod>2010-05-09T01:10:28Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/czech-republic-yearly-maintenance-fees</loc>
<lastmod>2010-05-09T00:49:20Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/news-bulgarian-drug-agency</loc>
<lastmod>2010-05-09T01:08:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/change-of-access</loc>
<lastmod>2010-05-09T01:09:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/difficulty-in-readability-testing</loc>
<lastmod>2010-05-09T01:07:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/blog</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/cefta</loc>
<lastmod>2010-05-02T23:27:12Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/cee-sourcing</loc>
<lastmod>2010-05-02T23:26:44Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/eu-enlargmet</loc>
<lastmod>2010-05-02T01:19:00Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/centralised-procedure-turkey</loc>
<lastmod>2010-05-09T01:31:57Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/ncadreac-agreement</loc>
<lastmod>2010-05-09T01:06:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/introduction-of-braille-script-for-pharmaceuticals-in-ukraine</loc>
<lastmod>2010-05-09T00:54:25Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/russia-s-emerging-otc-market-holds-problems-as-well-as-promise</loc>
<lastmod>2010-05-09T01:33:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/registration-of-the-drugs-in-the-republic-of-albania</loc>
<lastmod>2010-05-09T00:46:52Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/registration-of-herbal-medical-products-in-albania</loc>
<lastmod>2010-05-20T21:42:57Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/the-food-supplements-registration-in-albania</loc>
<lastmod>2010-05-20T21:42:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/variations</loc>
<lastmod>2010-05-20T21:41:18Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/act-on-medical-products-and-medical-devices</loc>
<lastmod>2010-05-20T21:40:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/ukraine-in-prospect-of-joining-pic-s</loc>
<lastmod>2010-07-15T12:14:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/emea/blog</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/emea/counterfeit-of-medical-products</loc>
<lastmod>2010-04-30T14:23:55Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/north-america/blog</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/north-america/fda-improves-generic-drug-access</loc>
<lastmod>2010-05-02T23:46:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/north-america/regulatory-updates-free-webinar-series</loc>
<lastmod>2010-05-09T00:56:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/regulatory-affairs-news/fibromyalgia</loc>
<lastmod>2010-05-24T13:43:14Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/other-issues/drug-repositioning</loc>
<lastmod>2010-05-02T23:43:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/regulatory-affairs-news/czech-information-for-m-a-h</loc>
<lastmod>2009-03-28T03:38:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/general-gulielines/nanotubes</loc>
<lastmod>2008-06-11T19:48:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/regulatory-affairs-news/first-farmavitar-regulanet-conference</loc>
<lastmod>2008-02-03T04:08:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/rx-to-otc/development-of-international-otc-bradns</loc>
<lastmod>2010-05-02T23:44:27Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/regulatory-affairs-news/regulatory-bodies-and-truth-about-cosmetic-ingredients</loc>
<lastmod>2007-11-26T04:54:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/regulatory-affairs-news/new-ra-alliance</loc>
<lastmod>2008-01-30T05:53:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/regulatory-affairs-news/strategic-ra-consulting</loc>
<lastmod>2007-09-27T21:03:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/general-gulielines/readability-qrd-testing</loc>
<lastmod>2008-05-24T18:16:02Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/other-issues/worlds-largest-patent-database-now-online</loc>
<lastmod>2010-05-02T23:50:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/other-issues/business-networking</loc>
<lastmod>2010-05-02T23:35:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/other-issues/business-strategies</loc>
<lastmod>2010-05-02T23:35:42Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/regulatory-affairs-news/hospital-in-the-home</loc>
<lastmod>2007-04-18T21:12:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/general-gulielines/ectd-viewer-validator</loc>
<lastmod>2008-05-24T18:20:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/general-gulielines/paediatric-medicines</loc>
<lastmod>2008-05-24T18:16:33Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/other-issues/open-source-pharmaceuticals-new-business-model</loc>
<lastmod>2010-05-02T23:34:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/other-issues/patent-expiry-dates</loc>
<lastmod>2010-05-02T23:52:51Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/other-issues/evergreening</loc>
<lastmod>2010-05-02T23:53:33Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/general-gulielines/dmf-project</loc>
<lastmod>2008-05-24T18:17:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/general-gulielines/data-exclusivity</loc>
<lastmod>2008-05-24T18:17:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/general-gulielines/new-cadreac</loc>
<lastmod>2008-05-24T18:18:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/professional-articles/blog</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/standardization-of-herbal-drugs</loc>
<lastmod>2010-05-20T21:39:24Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/intellectual-properties-rights</loc>
<lastmod>2010-03-30T02:14:52Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/calonyction-muricatum</loc>
<lastmod>2008-01-19T05:49:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/india-survey-of-computer-skills</loc>
<lastmod>2007-12-24T05:24:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/acne-therapy</loc>
<lastmod>2007-12-24T04:46:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/dendrimers-drug-delivery-to-cancer</loc>
<lastmod>2008-01-30T05:56:12Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/proteomics</loc>
<lastmod>2007-12-16T04:08:02Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/pharmacosomes</loc>
<lastmod>2007-12-11T22:11:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/nanotubes-against-cancer</loc>
<lastmod>2008-01-30T05:57:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/a-breakthrough-on-stem-cells</loc>
<lastmod>2007-11-23T17:52:51Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/antimalarial-drugs</loc>
<lastmod>2008-01-27T01:18:25Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/medicinal-herbs</loc>
<lastmod>2007-08-07T06:55:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/skin-cancer-therapy</loc>
<lastmod>2007-08-05T04:21:56Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/surveillance-of-some-recent-proton-pump-inhibitors</loc>
<lastmod>2007-07-08T05:29:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/semisolid-dosage-form</loc>
<lastmod>2010-05-02T23:51:28Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/wounds-healing</loc>
<lastmod>2007-07-08T05:35:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/life-science-article/drug-delivery</loc>
<lastmod>2010-05-02T01:34:24Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/clinical-trilas/blog</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/emerging-clinical-trial-locations</loc>
<lastmod>2010-05-02T01:46:45Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/asia/clinical-trial-in-india</loc>
<lastmod>2010-05-20T21:38:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/clinical-trial-design</loc>
<lastmod>2010-05-02T01:44:57Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/european-union/postmarketing-clinical-research</loc>
<lastmod>2010-05-02T01:48:02Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/clinical-trials-research</loc>
<lastmod>2010-05-02T01:49:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/eclinical-trials</loc>
<lastmod>2010-05-02T01:42:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/europe-not-eu/clinical-research</loc>
<lastmod>2010-05-02T01:41:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/pricing-and-reimbursment/blog</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/pricing-and-reimbursment/advertising-of-reimbursed-drugs</loc>
<lastmod>2010-05-12T15:06:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/pricing-and-reimbursment/pricing-and-reimbursement-conference-review</loc>
<lastmod>2010-05-06T03:09:02Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/pricing-and-reimbursment/croatia-pricing-and-reimbursement-news</loc>
<lastmod>2010-05-06T03:08:38Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/pricing-and-reimbursment/pricing-reimbursement</loc>
<lastmod>2010-05-06T03:09:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/pricing-and-reimbursment/pharmaceutical-pricing-and-reimbursement</loc>
<lastmod>2010-05-06T03:10:01Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/qa-and-gmp/blog</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/gmp-glp-gcp-gdp/understanding-usp-71-sterility-tests-and-extended-bud</loc>
<lastmod>2010-08-25T14:31:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/gmp-glp-gcp-gdp/management-practice</loc>
<lastmod>2010-05-02T23:41:54Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/gmp-glp-gcp-gdp/api-audit</loc>
<lastmod>2010-05-06T03:16:54Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/pharmacovigilance/blog</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/events/blog</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/events/pharmaceutical-pricing-reimbursement-in-turkey</loc>
<lastmod>2010-09-03T17:54:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/events/adaptive-clinical-trials</loc>
<lastmod>2010-07-23T14:23:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/events/clinical-trials-2010</loc>
<lastmod>2010-07-20T13:29:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/events/how-to-run-the-right-clinical-trials</loc>
<lastmod>2010-07-14T13:26:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/events/achieving-preferential-patient-access-through-innovative-agreements-with-payers</loc>
<lastmod>2010-07-09T18:08:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/events/long-term-pricing-reimbursement-strategies-to-penetrate-significant-growth-markets</loc>
<lastmod>2010-07-09T15:33:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/events/drug-repositioning-r-d-enhancement</loc>
<lastmod>2010-07-08T13:20:56Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/events/evolution-summit-2010</loc>
<lastmod>2010-07-08T13:21:25Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/events/ectd</loc>
<lastmod>2010-06-11T15:21:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/aboutus/about-us</loc>
<lastmod>2010-05-20T14:08:33Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/aboutus/advertising</loc>
<lastmod>2010-05-20T14:10:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/about-us/contacts</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/croatia-headquarters</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/bulgaria-brach-office</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/romania-brach-office</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/turkey-brach-office</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/macedonia-brach-office</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/bosnia-and-herzegovin-brach-office</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/serbia-montenegro-brach-office</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/hungary-brach-office</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/slovak-republic-brach-office</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/czech-republic-brach-office</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/kosovo-branch-office</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/albania-branch-office</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/contact-us/contacts/germany-r-partner</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Regulatory-Affairs-Files/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Regulatory-Affairs-Files/REG_84_version_1.pdf/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Regulatory-Affairs-Files/newcadreac.pdf/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Regulatory-Affairs-Files/Borderline-Products-legislation-and-implementation/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Scientific-Files/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Scientific-Files/Medicinal-Herbs/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Scientific-Files/EVALUATION-OF-ANTIMALARIAL-HERBS/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Scientific-Files/The-Future-of-the-Life-Scineces/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Scientific-Files/Intellectual-Property-Rights/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Scientific-Files/Standardization-of-Herbal-Drugs/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Scientific-Files/Clinical-Trial-in-India/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Scientific-Files/ANTIHYPERTENSION-MANAGEMENT-AND-DRUG-THERAPY;-A-MARKET-SURVEY/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Scientific-Files/Nanotubes-Against-Cancer/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presentations-from-FDA/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/Turkey/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/Coratia/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/Coratia/Croatia---List-of-reimbursement-pharmaceuticals-and-prices/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/Czech-Rep./</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/Czech-Rep./OTC-Czech--republic/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/Hungary/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/Hungary/Business-Advertising-Activity/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/Hungary/Hungarina-Act-on-the-General-Rules-of-Administrative-Proceedings-and-Services/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/Albania-Medical-Product-Registration/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/REGULATION-ON-HERBAL-MEDICINAL-PRODUCTS-FOR-HUMAN-USE-IN-THE-REPUBLIC-OF-ALBANIA/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/The-Food-Supplements-Registration-in-Albania/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/Variations/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/Act-on-Medical-Products-and-Medical-Devices/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/National-Law-and-Guidelines/The-Biotechnology-for-Europe-Study/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presenatations-from-National--Authorities/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presenatations-from-National--Authorities/Turkey/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presenatations-from-National--Authorities/Turkey/Pharmacovigilance-System-in-Turkey/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presenatations-from-National--Authorities/Albania---Country-Report/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presentations-from-EMEA/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presentations-from-EMEA/Biosimilars-Guidelines-and-current-experience/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presentations-from-EMEA/Clarification-on-traditional-herbal-products-and-fast-track-registration-process/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presentations-from-EMEA/Classification-issues-and-possible-switch-to-OTC/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presentations-from-EMEA/EudraVigilance-and-Risk-Management-within-the-EU-Pharmacovigilance-System/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presentations-from-EMEA/Incentives-for-orphan-drugs-paediatric-medicines-and-SMEs/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.farmavitar.com/repository/Presentations-from-EMEA/Outline-of-the-EU-pharmacovigilance-system/</loc>
<lastmod>2010-09-08T10:53:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
</urlset>
